Effects of equol supplement on bone and cardiovascular parameters in middle-aged Japanese women: A prospective observational study

Journal of Alternative and Complementary Medicine

Volumn 24, Issue 7, 2018, Pages 701-708

  Yoshikata, Remi ^a,b   Myint, Khin Zay Yar ^b   Ohta, Hiroaki ^c  

^a Hamasite Clinic   (Japan)

^b Tokyo Midtown Medical Center   (Japan)

^c Sanno Medical Center   (Japan)

Author keywords

bone parameters; cardiovascular parameters; equol; Japanese women; supplement

Indexed keywords

AMINO TERMINAL TELOPEPTIDE; EQUOL; PARATHYROID HORMONE; TRIACYLGLYCEROL; COLLAGEN TYPE 1; COLLAGEN TYPE I TRIMERIC CROSS-LINKED PEPTIDE; LIPID; PEPTIDE;

ADULT; ARTERIAL STIFFNESS; ARTERIOSCLEROSIS; ARTICLE; BRANCHIAL ANKLE PULSE WAVE VELOCITY; CARDIOVASCULAR PARAMETERS; CARDIOVASCULAR RISK; DIETARY SUPPLEMENT; DRUG EFFECT; DRUG SAFETY; DRUG TOLERABILITY; FEMALE; FRACTURE; HIGH RISK POPULATION; HORMONE SUBSTITUTION; HUMAN; HYPERTRIGLYCERIDEMIA; JAPANESE (PEOPLE); MAJOR CLINICAL STUDY; MIDDLE AGED; MUSCULOSKELETAL SYSTEM PARAMETERS; OBSERVATIONAL STUDY; OSTEOLYSIS; PARATHYROID HORMONE BLOOD LEVEL; PRIORITY JOURNAL; PROSPECTIVE STUDY; PULSE WAVE; TRIACYLGLYCEROL BLOOD LEVEL; BLOOD; TREATMENT OUTCOME; URINE;

COLLAGEN TYPE I; EQUOL; FEMALE; HUMANS; LIPIDS; MIDDLE AGED; PARATHYROID HORMONE; PEPTIDES; PROSPECTIVE STUDIES; TREATMENT OUTCOME; VASCULAR STIFFNESS;

EID: 85049174886     PISSN: 10755535     EISSN: 15577708     Source Type: Journal    
DOI: 10.1089/acm.2018.0050     Document Type: Article

References (49)

1. Xu X, Harris K, Wang H, Murphy P. Bioavailability of soybean isoflavones depends upon gut microflora in women. J Nutr 1995;125:2307-2315.
2. Liu Y, Hu M. Absorption and metabolism of flavonoids in the Caco-2 cell culture model and a perused rat intestinal model. Drug Metab Dispos 2002;30:370-377.
3. Griffiths LA, Barrow A. Metabolism of flavonoid compounds in germ-free rats. Biochem J 1972;72:1161-1162.
4. Day A, Dupont M, Ridley S, et al. Deglycosylation of flavonoid and isoflavonoid glycosides by human small intestine and liver b-glucosidase activity. Febs Lett 1998;436: 71-75.
5. Atkinson C, Frankenfield CL, Lampe JW. Gut bacterial metabolism of the soy isoflavone daidzein: Exploring the relevance to human health. Exp Biol Med 2005;230:155-170.
6. Decroos K, Vanhemmens S, Cattoir S, et al. Isolation and characterisation of an equol-producing mixed microbial culture from a human faecal sample and its activity under gastrointestinal conditions. Arch Microbiol 2005;183:45-55.
7. Miura A, Sugiyama C, Sakakibara H, et al. Bioavailability of isoflavones from soy products in equol producers and non-producers in Japanese women. J Nutr Intermed Metab 2016;6:41-47.
8. Rafii F. The role of colonic bacteria in the metabolism of the natural isoflavone daidzin to equol. Metabolites 2015;5: 56-73.
9. Van de Merwe JP, Stegeman JH, Hazenberg MP. The resident faecal flora is determined by genetic characteristics of the host. Implications for Crohn's disease? Antonie Van Leeuwenhoek 1983;49:119-124.
10. Yoshikata R, Myint KZ, Ohta H. Relationship between equol producer status and metabolic parameters in 743 Japanese women. Menopause 2017;24:216-222.
11. Van der Velpen V, Hollman PC, van Nielen M, et al. Large inter-individual variation in isoflavone plasma concentration limits use of isoflavone intake data for risk assessment. Eur J Clin Nutr 2014;68:1141-1147.
12. Franke AA, Lai JF, Halm BM, et al. Equol production changes over time in postmenopausal women. J Nutr Biochem 2012;23:573-579.
13. Klinge CM. Estrogen receptor interaction with estrogen response elements. Nucleic Acids Res 2001;29:2905-2919.
14. Marino M, Galluzzo P, Ascenzi P. Estrogen signaling multiple pathways to impact gene transcription. Curr Genomics 2006;7:497-508.
15. Nilsson S, Makela S, Treuter E, et al. Mechanisms of estrogen action. Physiol Rev 2001;81:1535-1565.
16. Heldring N, Pike A, Andersson S, et al. Estrogen receptors: How do they signal and what are their targets. Physiol Rev 2007;87:905-931.
17. Ishiwata N, Melby MK, Mizuno S, Watanabe S. New equol supplement for relieving menopausal symptoms: Randomized, placebo-controlled trial of Japanese women. Menopause 2009;16:141-148.
18. Aso T. Equol improves menopausal symptoms in Japanese women. J Nutr 2010;140:1386S-1389S.
19. Potter SM, Baum JA, Teng H, et al. Soy protein and isoflavones: Their effects on blood lipids and bone density in postmenopausal women. Am J Clin Nutr 1998;68:1375S-1379S.
20. Morabito N, Crisafulli A, Vergara C, et al. Effects of genistein and hormone-replacement therapy on bone loss in early postmenopausal women: A randomized double-blind placebo-controlled study. J Bone Miner Res 2002;17:1904-1912.
21. Alekel DL, Germain AS, Peterson CT, et al. Isoflavone-rich soy protein isolate attenuates bone loss in the lumbar spine of perimenopausal women. Am J Clin Nutr 2000;72:844-852.
22. Zheng W, Dai Q, Custer LJ, et al. Urinary excretion of isoflavonoids and the risk of breast cancer. Cancer Epidemiol Biomarkers Prev 1999;8:35-40.
23. Ingram D, Sanders K, Kolybaba M, Lopez D. Case-control study of phyto-oestrogens and breast cancer. Lancet 1997; 350:990-994.
24. Akaza H, Miyanaga N, Takashima N, et al. Is daidzein nonmetabolizer a high risk for prostate cancer? A case-controlled study of serum soybean isoflavone concentration. Jpn J Clin Oncol 2002;32:296-300.
25. Ozasa K, Nakao M, Watanabe Y, et al. Serum phytoestrogens and prostate cancer risk in a nested case-control study among Japanese men. Cancer Sci 2004;95:65-71.
26. Lephart ED. Skin aging and oxidative stress: Equol's antiaging effects via biochemical and molecular mechanisms. Ageing Res Rev 2016;11:36-54.
27. Mauvais-Jarvis F, Clegg DJ, Hevener AL. The role of estrogens in control of energy balance and glucose homeostasis. Endocr Rev 2013;34:309-338.
28. Usui T, Tochiya M, Sasaki Y, et al. Effects of natural Sequol supplements on overweight or obesity and metabolic syndrome in the Japanese, based on sex and equol status. Clin Endocrinol 2013;78:365-372.
29. Jenks BH, Iwashita S, Nakagawa Y, et al. A pilot study on the effects of S-equol compared to soy isoflavones on menopausal hot flash frequency. J Womens Health (Larchmt) 2012;21:674-682.
30. Hazim S, Curtis PJ, Schar MY, et al. Acute benefits of the microbial-derived isoflavone metabolite equol on arterial stiffness in men prospectively recruited according to equol producer phenotype: A double-blind randomized controlled trial. Am J Clin Nutr 2016;103:694-702.
31. Lampe JW, Karr SC, Hutchins AM, Slavin, JL. Urinary equol excretion with a soy challenge: influence of habitual diet. Proc Soc Exp Biol Med 1998;217:335-339.
32. Rowland IR, Wiseman H, Sanders TAB, et al. Interindividual variation in metabolism of soy isoflavones and lignans: Influence of habitual diet on equol production by the gut microflora nutrition and cancer. Nutr Cancer 2000;36:27-32.
33. Tormala RM, Appt S, Clarkson TB, et al. Individual differences in equol production capability modulate blood pressure in tibolone-treated postmenopausal women: Lack of effect of soy supplementation. Climacteric 2007;10:471-479.
34. Tormala RM, Appt S, Clarkson TB, et al. Equol production capability is associated with favorable vascular function in postmenopausal women using tibolone; no effect with soy supplementation. Atherosclerosis 2008;198:174-178.
35. Ahuja V, Miura K, Vishnu A, et al. Significant inverse association of equol-producer status with coronary artery calcification but not dietary isoflavones in healthy Japanese men. Brit J Nutr 2017;117:260-266.
36. Joy S, Siow RC, Rowlands DJ, et al. The isoflavone Equol mediates rapid vascular relaxation: Ca2+-independent activation of endothelial nitric-oxide synthase/Hsp90 involving ERK1/2 and Akt phosphorylation in human endothelial cells. J Biol Chem 2006;281:27335-27345.
37. Kang JS, Yoon YD, Han MH, et al. Equol inhibits nitric oxide production and inducible nitric oxide synthase gene expression through down-regulating the activation of Akt. Int Immunopharmacol 2007;7:491-499.
38. Meyer BJ, Larkin TA, Owen AJ, et al. Limited lipidlowering effects of regular consumption of whole soybean foods. Ann Nutr Metab 2004;48:67-78.
39. Cheong SH, Furuhashi K, Ito K, et al. Antihyperglycemic effect of equol, a daidzein derivative, in cultured L6 myocytes and ob/ob mice. Mol Nutr Food Res 2014;58: 267-277.
40. Khosla S, Riggs B. Pathophysiology of age-related bone loss and osteoporosis. Endocrinol Metab Clin N Am 2005; 34:1015-1030.
41. Ishimi Y. Dietary equol and bone metabolism in postmenopausal Japanese women and osteoporotic mice. J Nutr 2010;140:1373S-1376S.
42. Weaver C, Legette L. Equol, via dietary sources or intestinal production, may ameliorate estrogen deficiencyinduced bone loss. J Nutr 2010;140:1377S-1379S.
43. Taku K, Melby MK, Kurzer MS, et al. Effects of soy isoflavone supplements on bone turnover markers in menopausal women: Systematic review and meta-analysis of randomized controlled trials. Bone 2010;47:413-423.
44. Ohtomo T, UeharaM, Penalvo JL, et al. Comparative activities of daidzein metabolites, equol and O-desmethylangolensin, on bone mineral density and lipid metabolism in ovariectomized mice and in osteoclast cell cultures. Eur J Nutr 2008;47:273-279.
45. Shimada T, Kakitani M, Yamazaki Y, et al. Targeted ablation of Fgf23 demonstrates an essential physiological role of FGF23 in phosphate and vitamin D metabolism. J Clin Invest 2004;113:561-568.
46. Carrillo-Lopez N, Roman-Garcia P, Rodriguez-Rebollar A, et al. Indirect Regulation of PTH by Estrogens May Require FGF23. J Am Soc Nephrol 2009;20:2009-2017.
47. Uemura H, Irahara M, Yoneda N, et al. Close correlation between estrogen treatment and renal phosphate reabsorption capacity. J Clin Endocrinol Metab 2000;85:1215-1219.
48. Davinelli S, Scapagnini G, Marzatico F, et al. Influence of equol and resveratrol supplementation on health-related quality of life in menopausal women: A randomized, placebo-controlled study. Maturitas 2017;96:77-83.
49. Kruger MC, Middlemiss C, Katsumata S, et al. The effects of green kiwifruit combined with isoflavones on equol production, bone turnover and gut microflora in healthy postmenopausal women. Asia Pac J Clin Nutr 2018;27:347.